myriad genetics stock analysis
As of the latest analysis there are 4263582 shares shorted. Free Stock Analysis Report BioRad Laboratories Inc.
Myriad Genetics Inc Mygn Stock 10 Year History
Only 170 of the stock of Myriad Genetics is held by insiders.
. We explain how to buy Myriad Genetics Inc stock and compare the best stock trading platforms. 048 193 DATA AS OF Dec 20 2021 1001 AM ET. Myriad Genetics Inc a molecular diagnostic company focuses on the development and marketing of predictive medicine personalized medicine and prognostic medicine tests primarily in the United States.
MYGN Stock Analysis Overview What this means. The 8 analysts covering Myriad Genetics expect the company to break even for the first time. InvestorsObserver gives Myriad Genetics Inc MYGN an overall rank of 36 which is below average.
The company has a market cap of 184 billion a PE ratio of -6061 and a beta of 153. With 77476578 shares available for purchase and an average trading volume over the past 10 trading days of 475619 it would take at least 8964 days for all of the short holders to cover their shorts. MYGN Complete Myriad Genetics Inc.
Is a genetic testing and precision medicine company. Toggle menu toggle menu path dM526178 313114L447476 606733L741095 685435L819797 391816L526178 313114Z fillF9C32D. Stock news by MarketWatch.
In the past three months Myriad Genetics insiders have sold more of their companys stock than they have bought. Trading strategies financial analysis commentaries and investment guidance for MYRIAD GENETICS INC. MYGN stock analysis from Seeking Alphas top analysts.
A high-level overview of Myriad Genetics Inc. Learn about Myriad Genetics Inc MYGNXNAS stock quote with Morningstars rating and analysis and stay up to date with the current news price valuation dividends and other stock information to. Average annual earnings growth of 50 is required to achieve expected profit on schedule.
Myriad Genetics NASDAQMYGN - Get Rating last issued its earnings results on Thursday February 24th. Stay up to date on the latest stock price chart news analysis fundamentals trading and investment tools. Specifically they have bought 000 in company stock and sold 26250000 in company stock.
MYGN Myriad Genetics Inc. Percentage Held by Institutions. Myriad Genetics Inc.
MYGN Myriad Genetics - Stock quote performance technical chart analysis SmartSelect Ratings Group Leaders and the latest company headlines. New consensus forecast suggests the company will make a profit of US460m in 2024. The company reported 011 earnings per share EPS for the quarter beating.
The companys molecular diagnostic tests are designed to analyze genes their mutations expression levels and proteins to assess. Data is currently not available. Exclusive research and insights from bulls and bears.
Real time Myriad Genetics MYGN stock price quote stock graph news analysis. Free Stock Analysis Report AMN Healthcare Services Inc. View real-time stock prices and stock quotes for a full financial overview.
Myriad Genetics Inc MYGN. Quote Stock Analysis News Price vs Fair Value Sustainability Trailing Returns Financials. The Company primarily provides testing and collaborative development of testing that is designed to assess an individualâs risk for developing the disease later in life identify a patientâs likelihood of responding to drug therapy and guide a patientâs.
Myriad Genetics has a 52 week low of 2235 and a 52 week high of 3695. Find the latest Myriad Genetics Inc. Myriad Genetics Inc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stocks chart.
Common Stock MYGN Nasdaq Listed. Stock technical analysis with dynamic chart and Delayed Quote Nasdaq. See Myriad Genetics Inc.
Plus a detailed analysis for MYGN and full financial history. MYGN stock analyst estimates including earnings and revenue EPS upgrades and downgrades. Percentage Held by Insiders.
Technical Analysis Summary for Myriad Genetics Inc with Moving Average Stochastics MACD RSI Average Volume.
Mygn Stock Price And Chart Nasdaq Mygn Tradingview
Mygn Myriad Genetics Inc Stock Overview U S Nasdaq Barron S
Mygn Myriad Genetics Inc Stock Overview U S Nasdaq Barron S
Myriad Genetics Mygn Stock Price News Info The Motley Fool
Myriad Genetics Mygn To Offer Companion Diagnostic For Lynparza Nasdaq
Myriad Genetics Inc Mygn Stock 10 Year History
Myriad Genetics Inc Mygn Stock 10 Year History
Mygn Myriad Genetics Inc Stock Overview U S Nasdaq Barron S
3 Penny Stocks That Could Climb Over 140 Nasdaq
Reasons To Hold On To Myriad Genetics Mygn Stock For Now
Mygn Myriad Genetics Inc Stock Overview U S Nasdaq Barron S
Mygn Myriad Genetics Inc Stock Overview U S Nasdaq Barron S
Why Myriad Genetics Inc Stock Dropped 61 In 2016 The Motley Fool
Myriad Genetics Mygn Q3 Loss Wider Than Expected Revenues Top
World Gastroparesis Treatment Industry Is Expected To Grow At A Cagr Of 3 8 By 2023 Marketing Trends Competitive Analysis Emerging Technology
Myriad Genetics Shouldn T Overlook This Tiny Competitor Fox Business